Hoth Applies AI in Development of Candidate for KIT-Driven Cancers - Top-Institutions - MDSpire

Hoth Applies AI in Development of Candidate for KIT-Driven Cancers

Preclinical results and AI integration support progress toward regulatory submission

  • By

  • Julia Cipriano

  • March 19, 2026

  • 2 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Molecular Therapeutics
    • Rare Cancers
    • AI in Drug Development

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Molecular Oncology
    • Rare Tumors
    • Translational Research

  • #3

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Biology
    • Rare Cancers
    • Drug Development
    • AI in Oncology

  • #4

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Molecular Oncology
    • AI in Medicine
    • Rare Cancer Therapeutics

Original Source(s)

Hoth Applies AI in Development of Candidate for KIT-Driven Cancers

  • by Julia Cipriano

  • March 19, 2026

Related Content

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease